FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Dace Madore

Research Profile

Chemicals & Drugs

Living Beings

Disorders

Procedures

Anatomy

Bacterial Capsules

Co-author Network

Publications

TOP 3
Dace V Madore; Bruce D Meade; Fran Rubin; Carolyn Deal; Freyja Lynn
Utilization of serologic assays to support efficacy of vaccines in nonclinical and clinical trials: meeting at the crossroads.
Katherine L O'Brien; JENNIFER MOISI; Lawrence H Moulton; Dace V Madore; Angelia Eick; Raymond Reid; Robert Weatherholtz; Eugene V Millar; Diana Hu; Jill Hackell; Robert Kohberger; George R Siber; Mathuram Santosham
Predictors of pneumococcal conjugate vaccine immunogenicity among infants and toddlers in an American Indian PnCRM7 efficacy trial.
Eugene V Millar; Katherine L O'Brien; Melinda A Bronsdon; Dace V Madore; Jill Hackell; Raymond Reid; Mathuram Santosham
Anticapsular serum antibody concentration and protection against pneumococcal colonization among children vaccinated with 7-valent pneumococcal conjugate vaccine.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Dace Madore (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Dace V Madore; Bruce D Meade; Fran Rubin; Carolyn Deal; Freyja Lynn
Utilization of serologic assays to support efficacy of vaccines in nonclinical and clinical trials: meeting at the crossroads.
Vaccine 2010;28(29):4539-47.
2007: Katherine L O'Brien; JENNIFER MOISI; Lawrence H Moulton; Dace V Madore; Angelia Eick; Raymond Reid; Robert Weatherholtz; Eugene V Millar; Diana Hu; Jill Hackell; Robert Kohberger; George R Siber; Mathuram Santosham
Predictors of pneumococcal conjugate vaccine immunogenicity among infants and toddlers in an American Indian PnCRM7 efficacy trial.
The Journal of infectious diseases 2007;196(1):104-14.
2007: Eugene V Millar; Katherine L O'Brien; Melinda A Bronsdon; Dace V Madore; Jill Hackell; Raymond Reid; Mathuram Santosham
Anticapsular serum antibody concentration and protection against pneumococcal colonization among children vaccinated with 7-valent pneumococcal conjugate vaccine.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007;44(9):1173-9.
2005: Peter C Giardina; Emma Longworth; Renee E Evans-Johnson; Michaelene L Bessette; Hong Zhang; Ray Borrow; Dace V Madore; Philip Fernsten
Analysis of human serum immunoglobulin G against O-acetyl-positive and O-acetyl-negative serogroup W135 meningococcal capsular polysaccharide.
Clinical and diagnostic laboratory immunology 2005;12(5):586-92.
2005: Branda T Hu; Xinhong Yu; Thomas R Jones; Carol Kirch; Sarah Harris; Stephen W Hildreth; Dace V Madore; Sally A Quataert
Approach to validating an opsonophagocytic assay for Streptococcus pneumoniae.
Clinical and diagnostic laboratory immunology 2005;12(2):287-95.
2005: Daniel J Sikkema; Nancy A Ziembiec; Thomas R Jones; Stephen W Hildreth; Dace V Madore; Sally A Quataert
Assignment of weight-based immunoglobulin G1 (IgG1) and IgG2 units in antipneumococcal reference serum lot 89-S(F) for pneumococcal polysaccharide serotypes 1, 4, 5, 7F, 9V, and 18C.
Clinical and diagnostic laboratory immunology 2005;12(1):218-23.
2004: Sally A Quataert; Kate Rittenhouse-Olson; Carol S Kirch; Branda Hu; Shelley Secor; Nancy Strong; Dace V Madore
Assignment of weight-based antibody units for 13 serotypes to a human antipneumococcal standard reference serum, lot 89-S(f).
Clinical and diagnostic laboratory immunology 2004;11(6):1064-9.
2004: Robin E Huebner; Nontombi Mbelle; Bruce Forrest; Dace V Madore; keith klugman
Long-term antibody levels and booster responses in South African children immunized with nonavalent pneumococcal conjugate vaccine.
Vaccine 2004;22(21-22):2696-700.
2003: Peter C Giardina; Renee E Evans; Daniel J Sikkema; Dace V Madore; Stephen W Hildreth
Effect of antigen coating conditions on enzyme-linked immunosorbent assay for detection of immunoglobulin G antibody to Neisseria meningitidis serogroup Y and W135 capsular polysaccharide antigens in serum.
Clinical and diagnostic laboratory immunology 2003;10(6):1136-40.
2003: Catherine M Wernette; Carl E Frasch; Dace V Madore; George M Carlone; David Goldblatt; Bonnie B Plikaytis; William H Benjamin; Sally A Quataert; Stephen W Hildreth; Daniel J Sikkema; Helena Käyhty; Ingileif Jonsdottir; Moon H Nahm
Enzyme-linked immunosorbent assay for quantitation of human antibodies to pneumococcal polysaccharides.
Clinical and diagnostic laboratory immunology 2003;10(4):514-9.
2003: Susanna Esposito; Dace V Madore; Stefania Gironi; Samantha Bosis; Silvia Tosi; Ciro Bianchi; Carolyn Cimino; Nicola Principi
Theoretic coverage of heptavalent pneumococcal conjugate vaccine in the prevention of community-acquired pneumonia in children in Italy.
Vaccine 2003;21(21-22):2704-7.
2002: Kenneth T Mountzouros; Kelly A Belanger; Alan P Howell; Garvin S Bixler; Dace V Madore
A glycoconjugate vaccine for Neisseria meningitidis induces antibodies in human infants that afford protection against meningococcal bacteremia in a neonate rat challenge model.
Infection and immunity 2002;70(12):6576-82.
2002: Robin E Huebner; Nontombi Mbelle; Bruce Forrest; Dace V Madore; keith klugman
Immunogenicity after one, two or three doses and impact on the antibody response to coadministered antigens of a nonavalent pneumococcal conjugate vaccine in infants of Soweto, South Africa.
The Pediatric infectious disease journal 2002;21(11):1004-7.
2001: Sally A Quataert; D Martin; P Anderson; G S Giebink; J Henrichsen; M Leinonen; Dan M Granoff; H Russell; George R Siber; H Faden; D Barnes; Dace V Madore
A multi-laboratory evaluation of an enzyme-linked immunoassay quantitating human antibodies to Streptococcus pneumoniae polysaccharides.
Immunological investigations 2001;30(3):191-207.
2001: Margaret B Rennels; Kathryn M Edwards; Harry Keyserling; Keith S Reisinger; Mark M Blatter; Sally A Quataert; Dace V Madore; Ih Chang; Frank J Malinoski; Jill Hackell; Peter Paradiso
Safety and immunogenicity of four doses of Neisseria meningitidis group C vaccine conjugated to CRM197 in United States infants.
The Pediatric infectious disease journal 2001;20(2):153-9.
2000: Daniel J Sikkema; K E Friedman; B Corsaro; A Kimura; Stephen W Hildreth; Dace V Madore; Sally A Quataert
Relationship between serum bactericidal activity and serogroup-specific immunoglobulin G concentration for adults, toddlers, and infants immunized with Neisseria meningitidis serogroup C vaccines.
Clinical and diagnostic laboratory immunology 2000;7(5):764-8.
2000: Brian D Plikaytis; David Goldblatt; Carl E Frasch; C Blondeau; M J Bybel; G S Giebink; Ingileif Jonsdottir; Helena Käyhty; H B Konradsen; Dace V Madore; Moon H Nahm; C A Schulman; Patricia F Holder; T Lezhava; Cheryl M Elie; George M Carlone
An analytical model applied to a multicenter pneumococcal enzyme-linked immunosorbent assay study.
Journal of clinical microbiology 2000;38(6):2043-50.
2000: James C King; William Borkowsky; N Mahidhara; Dace V Madore; E D Shapiro; Richard M Rutstein; T Q Tan; John J Farley; Wayne M Dankner; Sharon Nachman; E Simoes; Patricia M Flynn; John Clemens; Robert G Hamilton
Group-specific antibody levels surrounding invasive pneumococcal illness in children infected with human immunodeficiency virus.
The Journal of infectious diseases 2000;181(5):1817-21.
2000: Steven Black; Henry Shinefield; Bruce Fireman; Edwin Lewis; Paula Ray; J R Hansen; Laura Elvin; Kathleen Ensor; Jill Hackell; George R Siber; Frank J Malinoski; Dace V Madore; Ih Chang; Robert Kohberger; W Watson; Robert Austrian; K Edwards
Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group.
The Pediatric infectious disease journal 2000;19(3):187-95.
1999: Henry Shinefield; Steven Black; Paula Ray; Ih Chang; N Lewis; Bruce Fireman; Jill Hackell; Peter Paradiso; George R Siber; Robert Kohberger; Dace V Madore; F J Malinowski; A Kimura; C Le; I Landaw; J Aguilar; John Hansen
Safety and immunogenicity of heptavalent pneumococcal CRM197 conjugate vaccine in infants and toddlers.
The Pediatric infectious disease journal 1999;18(9):757-63.
1999: Dace V Madore; Sally A Quataert
Interlaboratory reproducibility of an enzyme-linked immunosorbent assay for quantitation of antibodies for Haemophilus influenzae type b polysaccharide.
Clinical and diagnostic laboratory immunology 1999;6(3):446.
1999: Dace V Madore; N Strong; R Eby
Use of animal testing for evaluating glycoconjugate vaccine immunogenicity.
Developments in biological standardization 1999;101():49-56.
1999: Dace V Madore; C L Johnson-Kraines; E P Rothstein; David H Smith
Kinetics of antibody response to Haemophilus influenzae type b vaccines. Pennridge Pediatric Associates.
Current medical research and opinion 1999;15(2):105-12.
1998: Dace V Madore
Characterization of immune response as an indicator of Haemophilus influenzae type b vaccine efficacy.
The Pediatric infectious disease journal 1998;17(9 Suppl):S207-10.
1998: Margaret B Rennels; Kathryn M Edwards; Harry Keyserling; Keith S Reisinger; DA Hogerman; Dace V Madore; Ih Chang; Peter Paradiso; Frank J Malinoski; A Kimura
Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM197 in United States infants.
Pediatrics 1998;101(4 Pt 1):604-11.
1996: Katherine L O'Brien; mark steinhoff; K Edwards; H Keyserling; ML Thoms; Dace V Madore
Immunologic priming of young children by pneumococcal glycoprotein conjugate, but not polysaccharide, vaccines.
The Pediatric infectious disease journal 1996;15(5):425-30.
1996: James C King; Peter Vink; John J Farley; M Parks; M Smilie; Dace V Madore; Richard Lichenstein; Frank J Malinoski
Comparison of the safety and immunogenicity of a pneumococcal conjugate with a licensed polysaccharide vaccine in human immunodeficiency virus and non-human immunodeficiency virus-infected children.
The Pediatric infectious disease journal 1996;15(3):192-6.
1996: Dace V Madore
Impact of immunization on Haemophilus influenzae type b disease.
Infectious agents and disease 1996;5(1):8-20.
1996: Dace V Madore; P Anderson; B D Baxter; George M Carlone; Kathryn M Edwards; Robert G Hamilton; P Holder; H Käyhty; D C Phipps; C C Peeters; R Schneerson; G R Siber; J I Ward; C E Frasch
Interlaboratory study evaluating quantitation of antibodies to Haemophilus influenzae type b polysaccharide by enzyme-linked immunosorbent assay.
Clinical and diagnostic laboratory immunology 1996;3(1):84-8.
1995: Sally A Quataert; C S Kirch; L J Wiedl; D C Phipps; S Strohmeyer; C O Cimino; J Skuse; Dace V Madore
Assignment of weight-based antibody units to a human antipneumococcal standard reference serum, lot 89-S.
Clinical and diagnostic laboratory immunology 1995;2(5):590-7.
1995: Dace V Madore
Progress and challenges for a new combination vaccine composed of diphtheria, tetanus, acellular pertussis, and Haemophilus b conjugate.
Annals of the New York Academy of Sciences 1995;754():356-8.
1994: mark steinhoff; K Edwards; H Keyserling; ML Thoms; C Johnson; Dace V Madore; DA Hogerman
A randomized comparison of three bivalent Streptococcus pneumoniae glycoprotein conjugate vaccines in young children: effect of polysaccharide size and linkage characteristics.
The Pediatric infectious disease journal 1994;13(5):368-72.
1993: Peter Paradiso; DA Hogerman; Dace V Madore; H Keyserling; James C King; Keith S Reisinger; Mark M Blatter; Edward Rothstein; H H Bernstein; J Hackell
Safety and immunogenicity of a combined diphtheria, tetanus, pertussis and Haemophilus influenzae type b vaccine in young infants.
Pediatrics 1993;92(6):827-32.
1993: Steven B Black; Henry Shinefield; Paula Ray; Edwin M Lewis; Bruce Fireman; R Hiatt; Dace V Madore; C L Johnson; J G Hackell
Safety of combined oligosaccharide conjugate Haemophilus influenzae type b (HbOC) and whole cell diphtheria-tetanus toxoids-pertussis vaccine in infancy. The Kaiser Permanente Pediatric Vaccine Study Group.
The Pediatric infectious disease journal 1993;12(12):981-5.
1991: Edward Rothstein; Dace V Madore; Sarah S Long
Antibody persistence four years after primary immunization of infants and toddlers with Haemophilus influenzae type b CRM197 conjugate vaccine.
The Journal of pediatrics 1991;119(4):655-7.
1991: Edward Rothstein; R P Schiller; J A Girone; T J Hipp; R L Souder; H H Bernstein; Dace V Madore; C L Johnson; David H Smith
Response of 7- to 15-month-old infants to sequential immunization with Haemophilus influenzae type b-CRM197 conjugate and polysaccharide vaccines.
American journal of diseases of children (1960) 1991;145(8):898-900.
1991: Edward Rothstein; Dace V Madore; J A Girone; R P Schiller; T J Hipp; R L Souder; H H Bernstein
Comparison of antigenuria after immunization with three Haemophilus influenzae type b conjugate vaccines.
The Pediatric infectious disease journal 1991;10(4):311-4.
1990: D C Phipps; J West; R Eby; M Koster; Dace V Madore; Sally A Quataert
An ELISA employing a Haemophilus influenzae type b oligosaccharide-human serum albumin conjugate correlates with the radioantigen binding assay.
Journal of immunological methods 1990;135(1-2):121-8.
1990: Dace V Madore; C L Johnson; D C Phipps; M G Myers; R Eby; David H Smith
Safety and immunogenicity of Haemophilus influenzae type b oligosaccharide-CRM197 conjugate vaccine in infants aged 15 to 23 months.
Pediatrics 1990;86(4):527-34.
1990: Dace V Madore; C L Johnson; D C Phipps; L A Popejoy; R Eby; David H Smith
Safety and immunologic response to Haemophilus influenzae type b oligosaccharide-CRM197 conjugate vaccine in 1- to 6-month-old infants.
Pediatrics 1990;85(3):331-7.
1989: Dace V Madore; D C Phipps; R Eby; C L Johnson; David H Smith
Immune response of young children vaccinated with Haemophilus influenzae type b conjugate vaccines.
Contributions to microbiology and immunology 1989;10():125-50.